as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹1,589.5
Change
-6.7 (-0.42%)
Open
₹1,596.2
Prev. Close
₹1,596.2
Day High
₹1,604.5
Day Low
₹1,574.4
Volume Analysis
Traded
34,278
Delivered
20,367
Delivery %
59.42%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong operating margin (42.0%)
Weaknesses (0)
No signal for this stock
Opportunities (3)
- •Strong 3-year EPS growth (26.5%)
- •Strong 3-year revenue growth (19.2%)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹1,634.64 | ₹1,619.57 | ₹1,604.54 | ₹1,589.47 | ₹1,574.44 | ₹1,559.37 | ₹1,544.34 |
| Fibonacci | ₹1,619.57 | ₹1,608.07 | ₹1,600.97 | ₹1,589.47 | ₹1,577.97 | ₹1,570.87 | ₹1,559.37 |
| Camarilla | ₹1,597.78 | ₹1,595.02 | ₹1,592.26 | ₹1,589.47 | ₹1,586.74 | ₹1,583.98 | ₹1,581.22 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-1.3%
1 Week
-0.54%
1 Month
+0.35%
3 Months
-5.07%
6 Months
-7.89%
1 Year
+5.18%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹653.34
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
17.88%
Net margin 37.57% × asset turnover 0.4x × equity multiplier 1.19x
Company Overview
Sector
Financial Services
Market Cap
₹4,797 Cr
P/E (TTM)
24.9
ROE
19.7%
Book Value
₹333.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.
TopFund Analysis
Care Ratings Limited holds up reasonably well on TopFund's composite fundamentals check within the Financial Services sector, at 77/100. The strongest factor is Corporate Governance (100/100), while Momentum (44/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (42.0%). Strong 3-year EPS growth (26.5%).
TopFund Score — Fundamentals Quality
77/100 — GoodData confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company is almost debt free.
- +Company has been maintaining a healthy dividend payout of 43.8%
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
CGIL approved share transfer to SBI and NSEIX; it ceases being wholly owned, with CARE holding 80.20%.
CARE Ratings scheduled analyst/institutional investor meets on 18 and 20 November 2026.
Allotment of 16,133 equity shares pursuant to exercise of ESOP
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 96 | 79 | 90 | 79 | 117 | 96 | 110 | 94 | 136 | 112 | 131 | 112 | 164 |
| Expenses + | 55 | 55 | 61 | 57 | 62 | 66 | 62 | 66 | 68 | 72 | 70 | 77 | 80 |
| Operating Profit | 42 | 23 | 29 | 22 | 56 | 30 | 47 | 28 | 68 | 40 | 61 | 35 | 85 |
| OPM % | 43.0% | 30.0% | 32.0% | 28.0% | 47.0% | 32.0% | 43.0% | 30.0% | 50.0% | 36.0% | 46.0% | 31.0% | 52.0% |
| Other Income + | 11 | 14 | 10 | 12 | 12 | 12 | 15 | 14 | 13 | 13 | 16 | 15 | 15 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 |
| Profit before tax | 50 | 34 | 36 | 30 | 64 | 39 | 59 | 37 | 77 | 49 | 72 | 45 | 96 |
| Tax % | 29.0% | 30.0% | 32.0% | 30.0% | 27.0% | 27.0% | 26.0% | 29.0% | 26.0% | 25.0% | 26.0% | 27.0% | 24.0% |
| Net Profit + | 36 | 24 | 25 | 21 | 47 | 28 | 43 | 26 | 57 | 37 | 53 | 33 | 72 |
| EPS in Rs | 12 | 8 | 8 | 7 | 15 | 9 | 14 | 9 | 19 | 12 | 18 | 11 | 24 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | 14 | 27 | 16 | 19 | 22 | 22 | 22 | 19 | 16 | 16 | 19 | 19 | 20 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 261 | 279 | 287 | 333 | 319 | 244 | 248 | 248 | 279 | 332 | 402 | 473 | 519 |
| Expenses + | 101 | 105 | 105 | 122 | 144 | 162 | 153 | 168 | 180 | 220 | 247 | 276 | 298 |
| Operating Profit | 160 | 174 | 182 | 211 | 175 | 81 | 96 | 80 | 99 | 112 | 155 | 197 | 220 |
| OPM % | 61.0% | 62.0% | 63.0% | 63.0% | 55.0% | 33.0% | 39.0% | 32.0% | 36.0% | 34.0% | 39.0% | 42.0% | 42.0% |
| Other Income + | 44 | 9 | 34 | 25 | 30 | 31 | 31 | 27 | 38 | 47 | 51 | 55 | 59 |
| Interest | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 5 | 4 | 3 | 3 | 3 | 8 | 8 | 8 | 11 | 10 | 12 | 14 | 15 |
| Profit before tax | 197 | 178 | 212 | 233 | 202 | 104 | 119 | 99 | 126 | 147 | 192 | 235 | 262 |
| Tax % | 30.0% | 33.0% | 31.0% | 30.0% | 32.0% | 20.0% | 23.0% | 22.0% | 32.0% | 30.0% | 27.0% | 26.0% | — |
| Net Profit + | 138 | 120 | 148 | 162 | 138 | 83 | 91 | 77 | 85 | 103 | 140 | 174 | 195 |
| EPS in Rs | 48 | 41 | 50 | 55 | 47 | 28 | 30 | 25 | 28 | 34 | 46 | 57 | 64 |
| Dividend Payout % | 166.0% | 69.0% | 56.0% | 100.0% | 64.0% | 70.0% | 56.0% | 67.0% | 89.0% | 53.0% | 39.0% | 39.0% | — |
| Sales growth | 11 | 7 | 3 | 16 | -4 | -24 | 2 | 0 | 13 | 19 | 21 | 18 | 19 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 330 | 379 | 491 | 567 | 521 | 504 | 559 | 618 | 643 | 687 | 776 | 902 | 972 |
| Borrowings + | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 9 | 17 | 20 | 24 | 26 | 24 |
| Other Liabilities + | 87 | 94 | 64 | 61 | 64 | 85 | 74 | 69 | 80 | 105 | 128 | 146 | 170 |
| Total Liabilities | 446 | 502 | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 | 1,105 | 1,196 |
| Fixed Assets + | 65 | 64 | 61 | 60 | 83 | 93 | 85 | 96 | 107 | 109 | 119 | 122 | 123 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 8 | 4 | 6 | 3 | 5 | 0 |
| Investments | 335 | 381 | 466 | 518 | 439 | 339 | 240 | 44 | 44 | 44 | 134 | 87 | 188 |
| Other Assets + | 46 | 58 | 57 | 79 | 93 | 185 | 343 | 577 | 614 | 683 | 702 | 890 | 885 |
| Total Assets | 446 | 502 | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 | 1,105 | 1,196 |
| Equity Capital | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 30 | 30 | 30 | 30 | 30 | 30 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 107 | 106 | 119 | 134 | 109 | 67 | 86 | 68 | 82 | 91 | 123 | 148 |
| Cash from Investing Activity + | 157 | -41 | -22 | -25 | 83 | 27 | -38 | -27 | 13 | -39 | -58 | -94 |
| Cash from Financing Activity + | -276 | -66 | -96 | -99 | -195 | -107 | -43 | -35 | -63 | -63 | -54 | -59 |
| Net Cash Flow | -12 | -1 | 1 | 11 | -4 | -13 | 5 | 6 | 32 | -11 | 11 | -6 |
| Free Cash Flow | 96 | 104 | 118 | 131 | 82 | 63 | 82 | 49 | 71 | 82 | 108 | 140 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 104 | 95 | 101 | 95 | 98 | 125 | 114 | 122 | 115 | 119 | 112 | 107 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 51.99% | 50.2% | 50.47% | 49.92% | 47.74% | 46.87% | 45.61% | 44.79% | 45.7% | 45.37% | 45.01% | 44.18% |
| FII | 21.67% | 22.91% | 23.37% | 24.79% | 24.75% | 23.75% | 24.62% | 23.61% | 23.0% | 23.25% | 23.41% | 23.61% |
| DII | 26.32% | 26.89% | 26.15% | 25.28% | 27.5% | 29.38% | 29.76% | 31.6% | 31.3% | 31.38% | 31.58% | 32.22% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Financial Services — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Care Ratings Limited (this stock) | 4,797 | 24.9 | 4.78 | 19.7% |
| Mas Financial Serv Ltd | 4,774 | 11.4 | 1.48 | 13.4% |
| Seshaasai Technologies L | 4,927 | 17.8 | 3.24 | 23.3% |
| Pilani Inv & Ind Cor Ltd | 4,481 | 13.3 | 0.25 | 0.2% |
| Northern Arc Capital Ltd | 4,450 | 9.34 | 1.06 | 11.1% |
| Icra Limited | 4,304 | 21.4 | 3.61 | 16.7% |
| Sg Finserve Limited | 5,359 | — | 3.36 | — |
Which Mutual Funds Hold Care Ratings Limited?
Frequently Asked Questions about Care Ratings Limited
Care Ratings Limited (CARERATING) closed at ₹1,589.5 on NSE on 19 November 2026, down 6.7 (0.42%) from the previous close.
Care Ratings Limited trades on the NSE (National Stock Exchange of India) under the symbol CARERATING.
Care Ratings Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 24.9.
Care Ratings Limited has a dividend yield of 1.39%.
Care Ratings Limited's 52-week high is ₹1,838.0 and its 52-week low is ₹1,393.0.
Care Ratings Limited has a market capitalisation of ₹4,797 crore.
Care Ratings Limited has a TopFund Quality Score of 77/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Care Ratings Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.